DELIVERING EXCELLENCE IN RESEARCH AND INNOVATION
We hold an impressive track and record of innovation.
As a result of the extensive network of academicians, researchers, institutions and companies helping us worldwide to do this, we are now able to offer to our clients and their customers worldwide innovative solutions and services in different areas where we conduct business from fine chemicals to API´s, intermediates, reagents, industrial materials, raws, specialties, and many other from Biopharmaceuticals, Biochemicals, Industrial, Food & Nutrition or Agribusiness.
At Blackstone, we take the long view. It is vital to who we are and how we deliver market-leading performance. This long-term perspective is so ingrained in our culture that we singled it out in our initial public offering prospectus. Today, nearly 30 years since the founding of the firm, we still run the firm in the same way. That means thinking about the implications of every decision – from investments to growth initiatives, risk management to team building – in terms of years and decades rather than just months or quarters. We build to last.
We raise capital from the world’s leading investors and patiently deploy that capital in investments that we believe can safely generate the highest returns across market and economic cycles. In doing so, we have delivered exceptional investment returns for our Limited Partners for decades and enjoyed industry leading growth in assets under management, earnings and distributions to public unit holders.
A Portfolio of World-Class Research and Products
Our customers can benefit from our portfolio of products and outstanding services. Practicing the art of the long view has enabled us to outperform across the broad spectrum of products and services with specialization in hard-to-source molecules and compounds. We are sharply focused on delivering excellent performance, being responsible and aware of our customers business and expenditures, managing risk, seeking out new opportunities and pushing forward innovation. This approach has distanced ND Pharma from competitors that cannot match our scale, depth of talent or record.
Propelled by Innovation
Part of taking the long view is being willing to invest capital – both financial and human – in ventures that take time to pay off. ND Pharma is a true innovation machine, continually seeking out promising new products, markets and regions, in an all-effort to accomplish our customers needs. Each of our business platforms is charged with identifying new opportunities, developing sound strategies to build scale and market leadership, and deploying their best people to guide the success of new programs. This also provides a great career path for our exceptionally talented professionals.
Sustaining a Strong Culture
No company can grow at our rate and deliver outstanding results without an extraordinary culture. ND Pharma culture is defined by extremely talented individuals who have a passion for excellence, enormous energy and responsiveness and a real sense of purpose and integrity. We have never lost our small firm sensibility, where people know each other, share knowledge and have the freedom to innovate. Maintaining this culture over the long term is our enduring competitive advantage. By growing steadily and continuously innovating, we’ve engrained in the institution a means of capturing knowledge, evaluating risk and making decisions.
It is a privilege for us to share our success with our employees, investors and unit holders. And while we could not be more pleased with the firm’s extraordinary results to date, We are most excited about what the future holds.
As a result of the extensive network of academicians, researchers, institutions and companies helping us worldwide to do this, we are now able to offer to our clients and their customers worldwide innovative solutions and services in different areas where we conduct business from fine chemicals to API´s, intermediates, reagents, industrial materials, raws, specialties, and many other from Biopharmaceuticals, Biochemicals, Industrial, Food & Nutrition or Agribusiness.
At Blackstone, we take the long view. It is vital to who we are and how we deliver market-leading performance. This long-term perspective is so ingrained in our culture that we singled it out in our initial public offering prospectus. Today, nearly 30 years since the founding of the firm, we still run the firm in the same way. That means thinking about the implications of every decision – from investments to growth initiatives, risk management to team building – in terms of years and decades rather than just months or quarters. We build to last.
We raise capital from the world’s leading investors and patiently deploy that capital in investments that we believe can safely generate the highest returns across market and economic cycles. In doing so, we have delivered exceptional investment returns for our Limited Partners for decades and enjoyed industry leading growth in assets under management, earnings and distributions to public unit holders.
A Portfolio of World-Class Research and Products
Our customers can benefit from our portfolio of products and outstanding services. Practicing the art of the long view has enabled us to outperform across the broad spectrum of products and services with specialization in hard-to-source molecules and compounds. We are sharply focused on delivering excellent performance, being responsible and aware of our customers business and expenditures, managing risk, seeking out new opportunities and pushing forward innovation. This approach has distanced ND Pharma from competitors that cannot match our scale, depth of talent or record.
Propelled by Innovation
Part of taking the long view is being willing to invest capital – both financial and human – in ventures that take time to pay off. ND Pharma is a true innovation machine, continually seeking out promising new products, markets and regions, in an all-effort to accomplish our customers needs. Each of our business platforms is charged with identifying new opportunities, developing sound strategies to build scale and market leadership, and deploying their best people to guide the success of new programs. This also provides a great career path for our exceptionally talented professionals.
Sustaining a Strong Culture
No company can grow at our rate and deliver outstanding results without an extraordinary culture. ND Pharma culture is defined by extremely talented individuals who have a passion for excellence, enormous energy and responsiveness and a real sense of purpose and integrity. We have never lost our small firm sensibility, where people know each other, share knowledge and have the freedom to innovate. Maintaining this culture over the long term is our enduring competitive advantage. By growing steadily and continuously innovating, we’ve engrained in the institution a means of capturing knowledge, evaluating risk and making decisions.
It is a privilege for us to share our success with our employees, investors and unit holders. And while we could not be more pleased with the firm’s extraordinary results to date, We are most excited about what the future holds.
